Comparative study of efficacy and safety of ciprofloxacin and cefixime in the treatment of acute exacerbations of chronic bronchitis after first-line treatment failure. French Study Group.
Pulmonary Department, Charles-Nicolle Hospital, Rouen, France.
G
G
Nouvet
K
K
Benmessaoud
D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001991:Bronchitis / Q000150:complications* / Q000188:drug therapy* / Q000382:microbiology; D020682:Cefixime; D002439:Cefotaxime / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002908:Chronic Disease; D002939:Ciprofloxacin / Q000009:adverse effects* / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male
D000890:Anti-Infective Agents; D002939:Ciprofloxacin; D020682:Cefixime; D002439:Cefotaxime